期刊文献+

早期糖尿病视网膜病变模型大鼠玻璃体腔注射安维汀后房水细胞因子变化 被引量:2

Changes of cytokines in the aqueous humor following Avastin intravitreous injection in early diabetic retinopathy rats
下载PDF
导出
摘要 背景:关于抑制血管生成药安维汀治疗早期糖尿病视网膜病变大鼠的机制研究多数局限于血管内皮生长因子,而结缔组织生长因子和色素上皮衍生因子也在其中起重要的作用。目的:探讨安维汀玻璃体腔注射在早期糖尿病视网膜病变模型大鼠应用后房水细胞因子的变化及意义。方法:经链脲佐菌素诱导10周建立早期糖尿病视网膜病变模型大鼠,分别采用安维汀(1.25,2.5 mg)和生理盐水进行玻璃体腔注射。结果与结论:ELISA检测显示,与生理盐水注射组比较,两个安维汀注射组房水中血管内皮生长因子质量浓度降低,色素上皮衍生因子和结缔组织生长因子质量浓度增高(P<0.05),但两组间上述细胞因子的浓度差异无显著性意义(P>0.05)。结果证实,安维汀玻璃体腔注射在早期糖尿病视网膜病变大鼠应用促进新生血管的细胞因子血管内皮生长因子水平降低,抑制新生血管的细胞因子色素上皮衍生因子质量浓度升高,促进结缔组织生长因子水平升高。 BACKGROUND:Studies on the inhibitory mechanism of Avastin for early diabetic retinopathy rats are mostly confined to the vascular endothelial growth factor, while connective tissue growth factor and pigment epithelium-derived factor also play an important role in the disease. OBJECTIVE:To evaluate the changed cytokines of aqueous humor and significance of Avastin intravitreous injection in early diabetic retinopathy rats. METHODS:Rat models of early diabetic retinopathy were established by inducing with streptozotocin for 10 weeks. Avastin (1.25 mg and 2.5 mg) and physiological saline were injected in the vitreous space. RESULTS AND CONCLUSION:Enzyme linked immunosorbent assay results revealed that compared with the physiological saline injection group, mass concentration of vascular endothelial growth factor was reduced, mass&nbsp;concentrations of pigment epithelium-derived factor and connective tissue growth factor was increased in aqueous humor of the two Avastin injection groups (P0.05). Results verified that Avastin intravitreous injection decreased vascular endothelial growth factor levels, decreased pigment epithelium-derived factor mass concentration and increased connective tissue growth factor levels in rat models of early diabetic retinopathy.
出处 《中国组织工程研究》 CAS 北大核心 2015年第18期2933-2939,共7页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献45

  • 1许曼因.糖尿病学[M].上海:上海科学技术出版,2010.
  • 2Roden M. Diabetes mellitus: Definition, classification and diagnosis. Wien Klin Wochenschr. 2012;124 Suppl 2:1-3.
  • 3Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998-1003.
  • 4Adamis AP, AItaweel M, Bressler NM, et al. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology. 2006; 113(1 ):23-28.
  • 5Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26(3):275-278.
  • 6高玉,吴晋晖,柳林.链脲佐菌素诱发性糖尿病大鼠早期视网膜病变模型的建立[J].第二军医大学学报,2010,31(10):1053-1059. 被引量:23
  • 7Manik S, Gauttam V, Kalia AN. Anti-diabetic and antihyperlipidemic effect of allopolyherbal formulation in OGTT and STZ-induced diabetic rat model. ndian J Exp Biol. 2013;51 (9):702-708.
  • 8Sinapis CI, Routsias JG, Sinapis AI, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin(R)) in rabbits. Clin Ophthalmol. 2007;5:697-704.
  • 9董宇,李松鹤,孙雅彬,宋鄂,栾东风.金属锌对2型糖尿病大鼠模型视网膜病变的作用[J].中国实验诊断学,2010,14(4):514-516. 被引量:5
  • 10石静丽,阚红卫,王海青,梁燕,靳康,杨士友.2型糖尿病大鼠视网膜病变模型的建立及羟苯磺酸钙的干预作用[J].中国实验方剂学杂志,2011,17(23):180-183. 被引量:13

二级参考文献74

共引文献55

同被引文献35

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部